Developmental noise, ageing and cancer

Mechanisms of Ageing and Development

Volumn 124, Issue 6, 2003, Pages 711-720

  Aranda Anzaldo, Armando ^a   Dent, Myrna A R ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

Author keywords

Chance; Development; Morphogenesis; Oncogenes; p53; Reliability theory; Tumour suppressor genes

Indexed keywords

PROTEIN P53;

AGING; CANCER; CANCER INCIDENCE; CANCER INHIBITION; DEVELOPMENT; DISEASE COURSE; DISEASE PREDISPOSITION; EMBRYO CELL; HUMAN; MORPHOLOGY; NOISE; NONHUMAN; ORGANIZATION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENESCENCE; STOCHASTIC MODEL;

EID: 0038689151     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(03)00089-7     Document Type: Review

References (109)

1. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., Watson, J.D., 1994.Molecular Biology of the Cell, third ed. Garland Publishing, London, New York, pp. 1255-1294.
2. Alizadeh A.A., Eisen M.B., Eric Davis R., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson J., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Levy R., Wilson W., Grever M.R., Byrd J.C., Botstein D., Brown P.O., Staudt L.M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
3. Aranda-Anzaldo A. Cancer development and progression: a non-adaptive process driven by genetic drift. Acta Biotheor. 49:2001;89-108.
4. Aranda-Anzaldo A. Towards a morphogenetic perspective on cancer. Riv. Biol./Biol. Forum. 95:2002;35-62.
5. Aranda-Anzaldo A. Understanding cancer as a formless phenomenon. Med. Hypotheses. 59:2002;68-75.
6. Aranda-Anzaldo A., Orozco-Velasco F., García-Villa E., Gariglio P. p53 is a rate-limiting factor in the repair of higher-order DNA structure. Biochim. Biophys. Acta. 1446:(3):1999;181-192.
7. Armstrong J., Kaufman M.H., Harrison D.J., Clarke A.R. High frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5:1995;931-936.
8. Banfield A.W.F. The Mammals of Canada. 1974;438 University of Toronto Press, Toronto, Ont.
9. Barlow R.E., Proschan F., Hunter L.C. Mathematical Theory of Reliability. 1965;Wiley, New York.
10. Berry R.J., Bronson F.H. Life history and bioeconomy of the house mouse. Biol. Rev. Camb. Philos. Soc. 67:1992;519-550.
11. Breslow N., Chan C.W., Dhom G., Drury R.A., Franks L.M., Gellei B., Lee Y.S., Lundberg S., Sparke B., Sternby N.H., Tulinius H. Latent carcinoma of the prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int. J. Cancer. 20:1977;680-688.
12. Cancer Facts and Figures, 2002. American Cancer Society, Atlanta, pp. 1-7.
13. Cancer Official Websites: 1: http://www.cancerresearchuk.org; 2: http://www.cancerresearch.org; 3: http://seer.cancer.gov/publications/raterisk.
14. Chen M., Fernández H.L. Alzheimer movement re-examined 25 years later: is it a "disease" or a senile condition in medical nature. Front. Biosci. 6:2001;e30-e40.
15. Chung C.H., Bernard P.S., Perou C.M. Molecular portraits and the family tree of cancer. Nat. Genet. 32:(Suppl.):2002;533-540.
16. Cooper G.M. The Cell: A Molecular Approach. 1997;599-608 Sinauer-ASM Press, Sunderland, MA.
17. Curtsinger J.W., Fukui H.H., Townsend D.R., Vaupel J.W. Demography of genotypes: failure of the limited life-span paradigm in Drosophila melanogaster. Science. 258:1992;461-463.
18. DePinho R.A. The age of cancer. Nature. 408:2000;248-254.
19. Dollé M.E.T., Snyder W.K., Dunson D.B., Vijg J. Mutational fingerprints of aging. Nucleic Acids Res. 30:2002;545-549.
20. Donehower L.A. Does p53 affect organismal aging. J. Cell. Physiol. 192:2002;23-33.
21. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
22. Eizenberg O., Faberelman A., Gottlieb E., Oren M., Rotter V., Schwartz M. p53 plays a regulatory role in differentiation and apoptosis of the central nervous system-associated cells. Mol. Biol. Cell. 16:1996;5178-5185.
23. Etzioni R., Penson D., Legler J., di Tommasao D., Boer R., Gann P., Feuer E.J. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J. Natl. Cancer Inst. 94:2002;981-990.
24. Feirrera A., Kosic K.S. Accelerated neuronal differentiation induced by p53 suppression. J. Cell Sci. 109:1996;1509-1516.
25. Finch C.E. Longevity, Senescence and the Genome. 1990;504-536 University of Chicago Press, Chicago.
26. Finch C.E., Kirkwood T.B.L. Chance, Development and Aging. 2000;Oxford University Press, Oxford.
27. García-Cao I., García-Cao M., Martín-Caballero J., Criado L.M., Klatt P., Flores J.M., Weill J.-C., Blasco M.A., Serrano M. 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21:2002;6225-6235.
28. Gavrilov L.A., Gavrilova N.S. The reliability theory of aging and longevity. J. Theor. Biol. 213:2001;527-545.
29. Gavrilov L.A., Gavrilova N.S. Evolutionary theories of aging and longevity. Sci. World J. 2:2002;339-356.
30. Gersten O., Wilmoth J.R. The cancer transition in Japan since 1951. Demographic Res. 7:2002;271-306.
31. Getz L.L. A population study of the vole, Microtus pennsylvanicus. Am. Midland Naturalist. 64:1960;392-405.
32. Giese H., Snyder W.K., van Oostrom C., van Steeg H., Dolle M.E., Vijg J. Age-related mutation accumulation at a lacZ reporter locus in normal and tumor tissues of Trp53-deficient mice. Mutat. Res. 514:2002;153-163.
33. Godley L.A., Kopp J.B., Eckhaus M., Paglino J.J., Owens J., Varmus H.E. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev. 10:1996;836-850.
34. Griffiths A.J.F., Miller J.H., Suzuki D.T., Lewontin R.C., Gelbart W.M. Introduction to Genetic Analysis. sixth ed. 1996;14-17 Freeman, New York.
35. Guarente L., Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature. 408:2000;255-262.
36. Gyllenberg M., Webb G.F. Quiescence as an explanation of Gompertzian tumor growth. Growth Dev. Aging. 53:1989;25-33.
37. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature. 399:1999;464-468.
38. Hall P.A., Lane D.P. Tumour suppressors: a developing role for p53. Curr. Biol. 7:1997;R144-R174.
39. Hampton G.M., Frierson H.F. Classifying human cancer by analysis of gene expression. Trends Mol. Med. 9:2003;5-10.
40. Hayflick L. The future of aging. Nature. 408:2000;267-269.
41. Hemminiki K., Li X. Cancer risks in twins: results from the Swedish family-cancer database. Int. J. Cancer. 99:2002;873-878.
42. Herndon L.A., Schmelssner P.J., Dudaronek J.M., Brown P.A., Listner K.M., Sakano Y., Paupard M.C., Hall D.H., Driscoll M. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature. 419:2002;808-814.
43. Hoever M., Clement J.H., Wedlich D., Montenarh M., Kochel W. Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos. Oncogene. 9:1994;109-120.
44. Hua Luo J. Gene expression alterations in human prostate cancer. Drugs Today. 38:2002;713-719.
45. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1994;1-7.
46. Jackson M.A., Kovi J., Heshmat M.Y., Jones G.W., Rao M.S., Ahluwalia B.S. Factors involved in the high incidence of prostatic cancer among American blacks. Prog. Clin. Biol. Res. 53:1981;111-132.
47. Johnson M.L., Johnson S. Voles: Microtus species. Chapman J.A., Feldhamer G.A. Wild Mammals of North America: Biology, Management and Economics. 1982;326-354 The Johns Hopkins University Press, Baltimore, MD.
48. Jones S.N., Roe A.E., Donehower L.A., Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature. 378:1995;206-208.
49. Kirkwood T.B.L., Austad S.N. Why do we age. Nature. 408:2000;233-238.
50. Kothari M., Mehta L. The Other Face of Cancer. second ed. 2001;The Other India Press, Goa. Chapters 3, 11.
51. Koyi H., Hillerdal G., Branden E., Nordesjo L.O. The 'reservoir' of undetected bronchial carcinomas in the general population. Lung Cancer. 37:2002;137-142.
52. Land H., Parada L.F., Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 304:1983;596-602.
53. Lewin B. Genes VII. 2000;77 Oxford University Press, Oxford.
54. Lichtenstein P., Holm N.V., Verkasalo P.K., Iliadou A., Kaprio J., Kokenvuo M., Pukkala E., Skytthe A., Hemminiki K. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark and Finland. New Engl. J. Med. 343:2000;78-85.
55. Lin S.-J., Kaeberlein M., Andalis A.A., Sturtz L.A., Defossez P.-A., Culotta V.C., Fink G.R., Guarente L. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature. 418:2002;344-348.
56. Macieira-Coelho A. Neoplastic disease through the human life span. Biogerontology. 2:2001;179-192.
57. Matsudara P., Berk A., Zipursky L., Baltimore D., Darnell J., Lodish H. Molecular Cell Biology. fourth ed. 2000;1055 Freeman, New York.
58. Migliorini D., Denchi E.L., Danovi D., Jochemsen A., Capillo M., Gobbi A., Helin K., Pelicci P.G., Marine J.C. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic development. Mol. Cell. Biol. 22:2002;5527-5538.
59. Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA. 72:1975;3585-3589.
60. Montes de Oca Luna R., Wagner D.S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature. 378:1995;203-206.
61. Morales C.P., Holt S.E., Ouellette M., Kaur K.J., Yan Y., Wilson K.S., White M.A., Wright W.E., Shay J.W. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21:1999;115-118.
62. Mouse websites: http://www.geocities.com/therodentry/caresheets/Housemice.html; http://highered.mcgraw-hill.com/sites/0073031216/student_view0/excercise49/; http://centralpets.com/pages/critterpages/mammals/rodents/ROD5788.shtml; http://ladywildlife.com/animal/oldworldharvestmouse.html.
63. Müller W.H. Developmental Biology. 1997;174-184 Springer, New York.
64. Nakamura T., Pichel J.G., Williams Simons L., Westphal H. An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele. Proc. Natl. Acad. Sci. USA. 92:1995;6142-6146.
65. Nelson W.G., Kastan M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1994;1815-1823.
66. Nicol C.J., Harrison M.L., Laposa R.R., Gimelshtein I.L., Wells P.G. A teratologic suppressor role for p53 in benzo(a)pyrene-treated p53-deficient mice. Nat. Genet. 10:1995;181-187.
67. Norimura T., Nomoto S., Katsuki M., Gondo Y., Kondo S. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med. 2:1996;577-580.
68. Pani L., Horal M., Loeken M.R. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev. 16:2002;676-680.
69. Parkin D.M., Muir C.S., Whelan S.L., Gao Y.T., Ferlay J., Powell J. Cancer Incidence in Five Continents. VI:1992;WHO, Lyon. IARC Scientific Publications No. 120.
70. Partridge L., Mangel M. Message from mortality: the evolution of death rates in the old. Trends Ecol. Evol. 14:1999;438-442.
71. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen-Dale A.-L., Brown P.O., Botstein D. Molecular portraits of human breast tumours. Nature. 406:2000;747-752.
72. Pike M.C., Forman D. Epidemiology of cancer. Franks L.M., Teich N.M. Introduction to the Cellular and Molecular Biology of Cancer. second ed. 1991;49-97 Oxford University Press, Oxford.
73. Prives C., Hall P.A. The p53 pathway. J. Pathol. 187:1999;112-126.
74. Queitsch C., Sangster T.A., Lindquist S. Hsp90 as a capacitor of phenotypic variation. Nature. 417:2002;618-624.
75. Rakayan V.K., Preis J., Morgan H.D., Whitelaw E. The marks, mechanisms and memory of epigenetic states in mammals. Biochem. J. 356:2001;1-10.
76. Rasnick D., Duesberg P. How aneuploidy affects metabolic control and causes cancer. Biochem. J. 340:1999;621-630.
77. Rattan S.I. Biogerontology: the next step. Ann. New York Acad. Sci. 908:2000;282-290.
78. Reich L. Microtus pennsylvanicus. Mammalian Species. 159:1981;1-8.
79. Retsky M.W., Wardwell R.H., Swartzendruber D.E., Headley D.L. Prospective computerised simulation of breast cancer: comparison of computer predictions with nine sets of biological and clinical data. Cancer Res. 47:1987;4982-4987.
80. Retsky M.W., Swartzendruber D.E., Wardwell R.H., Bame P.D. Is Gompertzian or exponential kinetics a valid description of individual cancer growth. Med. Hypotheses. 33:1990;95-106.
81. Reznick D., Ghalambor C., Nunney L. The evolution of senescence in fish. Mech. Ageing Dev. 123:2002;773-789.
82. Rich T., Allen R.L., Wyllie A.H. Defying death after DNA damage. Nature. 407:2000;777-783.
83. Rutherford S.L., Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature. 396:1998;336-342.
84. Sah V.P., Attardi L.D., Mulligan G.J., Williams B.O., Bronson R.T., Jacks T. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10:1995;175-180.
85. Sakr W.A., Haas G.P., Cassin B.F., Pontes J.E., Crissman J.D. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J. Urol. 150:(2 Pt 1):1993;379-385.
86. Seger Y.-R., García-Cao M., Piccini S., Lo Cunsolo C., Doglioni C., Blasco M.A., Hannon G.J., Maestro R. Transformation of normal human cells in the absence of telomerase activation. Cancer Cell. 2:2002;401-413.
87. Segi, M., Kurihara, M., 1972. Cancer mortality for selected cancer sites in 24 countries. No. 6 (1966-1967). Japan Cancer Society, Tokyo.
88. Shanley D.P., Kirkwood T.B.L. Caloric restriction and aging: a life history analysis. Evolution. 54:2000;740-750.
89. Sheer D. Chromosomes and cancer. Franks L.M., Teich N.M. Introduction to the Cellular and Molecular Biology of Cancer. second ed. 1991;269-295 Oxford University Press, Oxford.
90. Sherr C.J., Weber J.D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10:2000;94-99.
91. Skehan P. On the normality of growth dynamics of neoplasms in vivo: a data base analysis. Growth. 50:1986;496-515.
92. Smithers D.W. A Clinical Prospect of the Cancer Problem. 1960;Livingstone, Edinburgh, London.
93. Steel G.G. Growth Kinetics of Tumors. 1977;Clarendon Press, Oxford.
94. Stockdale F.E. Cancer growth and chemotherapy. Rubenstein E., Federman D.D. Scientific American Medicine. 2:1995;1-18 Scientific American Books. Chap. 12 (V).
95. Strehler B.L. Time, Cells and Aging. 1977;Academic Press, New York, London.
96. Tulinius H. Latent malignancies at autopsy: a little used source of information on cancer biology. IARC Sci. Publ. 112:1991;253-261.
97. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranoius N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Park S.H., Thompson T., Karsenty G., Bradley A., Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53.
98. Van Bokhoven H., McKeon F. Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans. Trends Mol. Med. 8:2002;133-139.
99. Vijg J., Dolle M.E. Large genome rearrangements as a primary cause of aging. Mech. Ageing Dev. 123:2002;907-915.
100. Vousden K.H. p53: death star. Cell. 103:2000;691-694.
101. Waddington C.H. Canalisation of development and the inheritance of acquired characters. Nature. 150:1942;563-565.
102. Wallingford J.B., Seufert D.W., Virta V.C., Vize P.D. p53 activity is essential for normal development in Xenopus. Curr. Biol. 7:1997;747-757.
103. Watson J.D., Gilman M., Witkowski J., Zoller M. Recombinant DNA. second ed. 1992;336 Freeman-Sci. Amer. Books, New York.
104. Weindruch R. Effect of caloric restriction on age-associated cancers. Exp. Gerontol. 27:1992;575-581.
105. Weindruch R., Walford R.L. Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science. 215:1982;1415-1418.
106. Weindruch R., Walford R.L. The Retardation of Aging and Disease by Dietary Restriction. 1998;Charles C. Thomas, Springfield, IL.
107. Weindruch R., Walford R.L., Fligiel S., Guthrie D. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J. Nutr. 116:1986;641-654.
108. Woods D.B., Vousden K.H. Regulation of p53 function. Exp. Cell Res. 264:2001;56-66.
109. Zimonjic D., Brooks M.W., Popescu N., Weinberg R.A., Hahn W.C. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res. 61:2001;8838-8844.